跳到正文
原文
STAT Pharma 医药频道· Jason Mast·· 2026-10-21AI 评分49

Mark Cuban 旗下 Cost Plus Drugs 将新工厂部分产能用于 n-of-1 罕见病药物生产

STAT+: Mark Cuban wants to crack open the market for rare disease treatments

AI 导读

Mark Cuban 旗下的 Cost Plus Drugs 已将新工厂的部分产能投入 n-of-1 定制罕见病药物生产,首批包括加州化学家为修补单个患者神经元基因突变而合成的类 DNA 分子,以及与荷兰研究者合作开发、针对一种成人进行性肌肉失控罕见病的类 DNA 分子。Cuban 在给 STAT 记者的邮件中称,这是帮助这类患者的一个明显机会,也是该公司在压低仿制药价格之外的新方向。

正文

Cost Plus Drugs commits part of new plant to making n-of-1 treatments

“Saw your article on baby KJ and n of 1 therapies,” Mark Cuban wrote to a STAT reporter. Now he has news with Cost Plus Drugs.Jason Mendez/Getty Images for Samsung Electronics America

By Jason Mast

Oct. 21, 2026

General Assignment Reporter

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77.

Billionaire Mark Cuban has spent the last five years trying to make generic drugs like chemotherapy and antifungal ointment cheaper for Americans. But earlier this year, a very different type of medicine began arriving at his Dallas factory. 

One shipment contained DNA-like molecules crafted by California chemists to patch the rare genetic mutation destroying a single patient’s neurons. Another carried DNA-like molecules developed with Dutch researchers to stop a rare disease that causes adults to progressively lose control of their muscles.

They are the first test of Cuban’s newest vision for his company Cost Plus Drugs: shake up the business of custom-made rare disease medicines. “It was an obvious chance for us to help those in that unfortunate situation,” he wrote in an email.

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

  1. General Assignment Reporter

    Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77.

来源:STAT Pharma 医药频道 · statnews.com